Clinical Trial Update: Study Evaluating the Effects of IMA-638 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 study of IMA-638 to evaluate allergen-induced airway responses in adults with mild atopic asthma. The trial is completed and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• IMA-638

Snippet

Sponsor: Pfizer | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2014-11-18